首页 > 最新文献

Journal of Endovascular Therapy最新文献

英文 中文
Bare Stent Fracture After TEVAR With the Modified Restrictive Bare Stent (RBS) Technique in Type B Aortic Dissections. 改良限制性裸支架(RBS)技术治疗B型主动脉夹层TEVAR后裸支架骨折。
IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 Epub Date: 2023-05-02 DOI: 10.1177/15266028231170114
Mario Lescan, Mateja Andic, Constantin Bonorden, Julia Schano, Julia Hahn, Christian Schlensak, Migdat Mustafi

Purpose: The aim was to assess the mid-term aortic remodeling and bare-metal stent (BMS) integrity of the restricted bare stent (RBS) technique reconstruction in aortic dissections.

Materials and methods: This retrospective cohort study included prospectively collected patients treated with the modified RBS technique between 2017 and 2020. The preoperative, postoperative, and last follow-up computed tomographic (CT) scans were analyzed in the centerline at the mid-descending, celiac trunk (CeT), and the mid-abdominal levels for false lumen (FL) patency, aortic diameter, and true lumen (TL) diameter changes. Bare-metal stent integrity was assessed in the 3-dimensional multiplanar reformats.

Results: The median follow-up of the cohort (n=17) was 26 (11, 45) months. The procedure was mainly performed with the Relay NBS endograft (15/17; 88%) + E-XL BMS (17/17; 100%). Postoperative mortality, paraplegia, stroke, renovisceral vessel loss, and type I and III endoleaks were not observed. BMS fractured in 6 patients (6/17; 36%), damaged the dissection flap in 4/17 (24%), and led to the reperfusion of the FL and re-interventions with TEVAR (4/17; 24%). Two patients without FL reperfusion showed stable CT follow-ups 13 and 17 months after the fracture diagnosis. The TL expansion was seen at all landmarks and peaked in the thoracic aorta (+10; 6, 15; p<0.001). The FL thrombosis after modified RBS was only relevant in the thoracic aorta (p<0.001) and at CeT (p=0.003). The aortic diameter was stable in the thoracic aorta and increased at distal landmarks (CeT [+5; 1, 10; p=0.001]; mid-abdominal [+3; 1, 5; p=0.004]).

Conclusion: The modified RBS technique could not stop aortic growth below the diaphragm and prevent new membrane rupture due to the fractures of the BMS and consecutive flap damage with the reperfusion of the FL.

Clinical impact: The treatment of complicated type B aortic dissections with TEVAR has become a standard. Particularly, patients with true lumen collapse and malperfusion may benefit from a more aggressive treatment strategy including proximal TEVAR and distal bare-metal stent implantation to re-open the true lumen and to prevent distal stent-induced new entry. However, this study reports the challenges of this approach with a high rate of bare-metal stent fractures during the follow-up. The fractures that occurred at the site of vertical nitinol bridges led to the dissection membrane ruptures and the reperfusion of the false lumen with consecutive dilatation. A close follow-up is mandatory to detect this complication and to treat the patients with TEVAR extension.

目的:评价主动脉夹层限制性裸支架(RBS)技术重建中期主动脉重构及裸金属支架(BMS)的完整性。材料和方法:本回顾性队列研究前瞻性收集了2017年至2020年期间接受改良RBS技术治疗的患者。术前、术后和最后随访的计算机断层扫描(CT)在中降、腹腔干(CeT)和腹中水平的中心线上分析假腔(FL)通畅、主动脉直径和真腔(TL)直径的变化。裸金属支架的完整性在三维多平面重构中进行评估。结果:该队列(n=17)的中位随访时间为26(11,45)个月。该手术主要采用Relay NBS内移植物(15/17;88%) + e-xl BMS (17/17;100%)。未观察到术后死亡率、截瘫、中风、肾脏血管丢失和I型和III型内漏。BMS骨折6例(6/17;36%), 4/17(24%)损伤夹层皮瓣,导致FL再灌注和TEVAR再干预(4/17;24%)。2例无FL再灌注的患者在骨折诊断后13个月和17个月CT随访稳定。TL扩张在所有标志处均可见,并在胸主动脉处达到高峰(+10;6, 15;结论:改良的RBS技术不能阻止膈下主动脉的生长,也不能阻止膈下主动脉因BMS断裂和fl再灌注时皮瓣连续损伤而导致的新膜破裂。临床影响:TEVAR治疗复杂的B型主动脉夹层已成为一种标准。特别是,真正的管腔衰竭和灌注不良的患者可能受益于更积极的治疗策略,包括近端TEVAR和远端裸金属支架植入,以重新打开真正的管腔,防止远端支架诱导的新进入。然而,这项研究报告了这种方法的挑战,在随访期间裸金属支架骨折的发生率很高。在垂直镍钛诺桥处发生骨折,导致分离膜破裂,假腔再灌注持续扩张。密切的随访是必要的,以发现这一并发症,并治疗患者的TEVAR延长。
{"title":"Bare Stent Fracture After TEVAR With the Modified Restrictive Bare Stent (RBS) Technique in Type B Aortic Dissections.","authors":"Mario Lescan, Mateja Andic, Constantin Bonorden, Julia Schano, Julia Hahn, Christian Schlensak, Migdat Mustafi","doi":"10.1177/15266028231170114","DOIUrl":"10.1177/15266028231170114","url":null,"abstract":"<p><strong>Purpose: </strong>The aim was to assess the mid-term aortic remodeling and bare-metal stent (BMS) integrity of the restricted bare stent (RBS) technique reconstruction in aortic dissections.</p><p><strong>Materials and methods: </strong>This retrospective cohort study included prospectively collected patients treated with the modified RBS technique between 2017 and 2020. The preoperative, postoperative, and last follow-up computed tomographic (CT) scans were analyzed in the centerline at the mid-descending, celiac trunk (CeT), and the mid-abdominal levels for false lumen (FL) patency, aortic diameter, and true lumen (TL) diameter changes. Bare-metal stent integrity was assessed in the 3-dimensional multiplanar reformats.</p><p><strong>Results: </strong>The median follow-up of the cohort (n=17) was 26 (11, 45) months. The procedure was mainly performed with the Relay NBS endograft (15/17; 88%) + E-XL BMS (17/17; 100%). Postoperative mortality, paraplegia, stroke, renovisceral vessel loss, and type I and III endoleaks were not observed. BMS fractured in 6 patients (6/17; 36%), damaged the dissection flap in 4/17 (24%), and led to the reperfusion of the FL and re-interventions with TEVAR (4/17; 24%). Two patients without FL reperfusion showed stable CT follow-ups 13 and 17 months after the fracture diagnosis. The TL expansion was seen at all landmarks and peaked in the thoracic aorta (+10; 6, 15; p<0.001). The FL thrombosis after modified RBS was only relevant in the thoracic aorta (p<0.001) and at CeT (p=0.003). The aortic diameter was stable in the thoracic aorta and increased at distal landmarks (CeT [+5; 1, 10; p=0.001]; mid-abdominal [+3; 1, 5; p=0.004]).</p><p><strong>Conclusion: </strong>The modified RBS technique could not stop aortic growth below the diaphragm and prevent new membrane rupture due to the fractures of the BMS and consecutive flap damage with the reperfusion of the FL.</p><p><strong>Clinical impact: </strong>The treatment of complicated type B aortic dissections with TEVAR has become a standard. Particularly, patients with true lumen collapse and malperfusion may benefit from a more aggressive treatment strategy including proximal TEVAR and distal bare-metal stent implantation to re-open the true lumen and to prevent distal stent-induced new entry. However, this study reports the challenges of this approach with a high rate of bare-metal stent fractures during the follow-up. The fractures that occurred at the site of vertical nitinol bridges led to the dissection membrane ruptures and the reperfusion of the false lumen with consecutive dilatation. A close follow-up is mandatory to detect this complication and to treat the patients with TEVAR extension.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"199-207"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9451541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elastic Deformation Measurement Using Duplex Ultrasound for the Detection of High Aneurysm Sac Pressure Following EVAR. 用双超声测量弹性变形检测EVAR后动脉瘤囊高压力。
IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 Epub Date: 2023-05-11 DOI: 10.1177/15266028231172400
Olton S van Genderen, Rob C van Wissen, Jaap F Hamming, Jan van Schaik, Joost R van der Vorst

Purpose: To describe the concept of aortic elastic deformation (ED) measurement using duplex ultrasonography (DUS) as a tool for detection of high aneurysm sac pressure following endovascular aortic repair (EVAR).

Technique: High aneurysm sac pressure, with or without proven endoleak, will result in a less compressible aneurysm. Using the dual image function in B-mode of the DUS device and a standardized amount of applied probe pressure, ED can be measured. It is defined as the percentage of deformation of the aneurysm sac on probe pressure application. We hypothesize that less ED of the aneurysm sac can be related with high aneurysm sac pressure and possibly the presence of clinically relevant endoleak. In this note, we describe the technical details of the procedure and report on the applicability and results of ED measurements in the framework of aortic aneurysm and EVAR follow-up in a cohort of 109 patients.

Conclusion: ED measurement is the first noninvasive pressure-based method in the quest to find a practical and reliable diagnostic tool to exclude high aneurysm sac pressure. In our patient cohort, patients with proven endoleak showed a smaller ED (less compressible), implying the presence of high aneurysm sac pressure. Further research should confirm whether ED measurement using DUS could reliably exclude endoleak after EVAR and further explore its potential for clinical application in EVAR follow-up.

Clinical impact: For the first time, a simple, fast, and inexpensive diagnostic tool is presented in this study for detecting high sac pressure following EVAR. High sac pressure is typically caused by clinically significant endoleaks, which can have significant consequences. Currently, computed tomography scanning is the most common method used to identify and characterize endoleaks. However, measuring elastic deformation may potentially replace more invasive and expensive modalities, such as the computed tomography in the future.

目的:描述用双工超声(DUS)测量主动脉弹性变形(ED)作为检测血管内主动脉修复(EVAR)后动脉瘤囊高压力的工具的概念。技术:高动脉瘤囊压力,无论有无证实的内漏,都会导致动脉瘤压缩性降低。利用DUS装置的b模式双图像功能和施加的标准探针压力量,可以测量ED。定义为探头施加压力时动脉瘤囊的变形百分比。我们推测动脉瘤囊ED的减少可能与动脉瘤囊压力高和可能存在临床相关的内漏有关。在这篇文章中,我们描述了手术的技术细节,并报告了ED测量在主动脉瘤和EVAR随访框架下的适用性和结果。结论:ED测量是第一个无创的基于压力的方法,旨在寻找一种实用可靠的诊断工具来排除高动脉瘤囊压力。在我们的患者队列中,证实有内漏的患者表现出较小的ED(可压缩性较差),这意味着存在较高的动脉瘤囊压力。进一步的研究应证实DUS测量ED是否能可靠地排除EVAR后的内漏,并进一步探讨其在EVAR随访中的临床应用潜力。临床影响:本研究首次提出了一种简单、快速、廉价的诊断工具,用于检测EVAR后的高囊压。高囊压通常是由临床显著的内漏引起的,这可能会产生严重的后果。目前,计算机断层扫描是最常用的方法,用于识别和表征内渗漏。然而,测量弹性变形可能会在未来取代更具侵入性和昂贵的方式,如计算机断层扫描。
{"title":"Elastic Deformation Measurement Using Duplex Ultrasound for the Detection of High Aneurysm Sac Pressure Following EVAR.","authors":"Olton S van Genderen, Rob C van Wissen, Jaap F Hamming, Jan van Schaik, Joost R van der Vorst","doi":"10.1177/15266028231172400","DOIUrl":"10.1177/15266028231172400","url":null,"abstract":"<p><strong>Purpose: </strong>To describe the concept of aortic elastic deformation (ED) measurement using duplex ultrasonography (DUS) as a tool for detection of high aneurysm sac pressure following endovascular aortic repair (EVAR).</p><p><strong>Technique: </strong>High aneurysm sac pressure, with or without proven endoleak, will result in a less compressible aneurysm. Using the dual image function in B-mode of the DUS device and a standardized amount of applied probe pressure, ED can be measured. It is defined as the percentage of deformation of the aneurysm sac on probe pressure application. We hypothesize that less ED of the aneurysm sac can be related with high aneurysm sac pressure and possibly the presence of clinically relevant endoleak. In this note, we describe the technical details of the procedure and report on the applicability and results of ED measurements in the framework of aortic aneurysm and EVAR follow-up in a cohort of 109 patients.</p><p><strong>Conclusion: </strong>ED measurement is the first noninvasive pressure-based method in the quest to find a practical and reliable diagnostic tool to exclude high aneurysm sac pressure. In our patient cohort, patients with proven endoleak showed a smaller ED (less compressible), implying the presence of high aneurysm sac pressure. Further research should confirm whether ED measurement using DUS could reliably exclude endoleak after EVAR and further explore its potential for clinical application in EVAR follow-up.</p><p><strong>Clinical impact: </strong>For the first time, a simple, fast, and inexpensive diagnostic tool is presented in this study for detecting high sac pressure following EVAR. High sac pressure is typically caused by clinically significant endoleaks, which can have significant consequences. Currently, computed tomography scanning is the most common method used to identify and characterize endoleaks. However, measuring elastic deformation may potentially replace more invasive and expensive modalities, such as the computed tomography in the future.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"43-46"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9796950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abdominal Aortic Endograft Implantation Immediately Induces Vascular Stiffness Gradients That May Promote Adverse Aortic Neck Dilatation: Results of A Porcine Ex Vivo Study. 一项猪离体研究的结果表明,腹主动脉内移植物植入会立即诱导血管僵硬梯度,从而可能促进不利的主动脉颈扩张。
IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 Epub Date: 2023-05-08 DOI: 10.1177/15266028231169178
Isabel N Schellinger, Jörg Naumann, Annett Hoffmann, Sarah-Jane Barnard, Sandra Düsing, Markus U Wagenhäuser, Josephina Haunschild, Dierk Scheinert, Gerd Hasenfuß, Christian D Etz, Uwe Raaz

Purpose: Endovascular aortic repair (EVAR) is the method of choice for most abdominal aortic aneurysm (AAA) patients requiring intervention. However, chronic aortic neck dilatation (AND) following EVAR progressively weakens the structural seal between vessel and endograft and compromises long-term results of the therapy. This experimental ex vivo study seeks to investigate mechanisms of AND.

Materials and methods: Porcine abdominal aortas (n=20) were harvested from slaughterhouse pigs and connected to a mock circulation. A commercially available endograft was implanted (n=10) or aortas were left untreated as controls (n=10). Vascular circumferential strain was assessed via ultrasound in defined aortic segments as a parameter of aortic stiffness. Histology and aortic gene expression analysis were performed to investigate potential changes of aortic wall structure and molecular differences due to endograft implantation.

Results: We found that endograft implantation acutely induces a significant stiffness gradient directly at the interface between stented and unstented aortic segments under pulsatile pressure. Comparing stented aortas with unstented controls, we detected increased aortic expression levels of inflammatory cytokines (Il6 and Ccl2) and matrix metalloproteinases (Mmp2 and Mmp9) after 6 hours of pulsatile pressurization. This effect, however, was abolished when repeating the same experiment under 6 hours of static pressure.

Conclusions: We identified endograft-induced aortic stiffness gradients as an early trigger of inflammatory aortic remodeling processes that might promote AND. These results highlight the importance of adequate endograft designs to minimize vascular stiffness gradients and forestall late complications, such as AND.

Clinical impact: AND may compromise the long-term results following endovascular aortic repair. However, the mechanisms behind the underlying detrimental aortic remodeling are still unclear. In this study we find that endograft-induced aortic stiffness gradients induce an inflammatory aortic remodeling response consistent with AND. This novel pathomechanistic insight may guide the design of new aortic endografts that minimize vascular stiffness gradients and forestall late complications such as AND.

目的:血管内主动脉修复(EVAR)是大多数需要介入治疗的腹主动脉瘤(AAA)患者的首选方法。然而,EVAR后的慢性主动脉颈扩张(AND)会逐渐削弱血管和内移植物之间的结构密封,影响治疗的长期效果。本实验旨在探讨AND的机制。材料和方法:猪腹主动脉(n=20)取材于屠宰场的猪,并连接到模拟循环系统。植入市售的内移植物(n=10)或不治疗主动脉作为对照(n=10)。通过超声在确定的主动脉段中评估血管周向应变,作为主动脉硬度的参数。通过组织病理学和主动脉基因表达分析,探讨主动脉壁结构的潜在变化和分子差异。结果:我们发现在脉动压力下,血管内植入术直接在支架和未支架主动脉段之间的界面处引起明显的刚度梯度。将支架置入的主动脉与未支架置入的对照组进行比较,我们检测到在脉动加压6小时后,主动脉炎症细胞因子(Il6和Ccl2)和基质金属蛋白酶(Mmp2和Mmp9)的表达水平升高。然而,当在6小时的静压下重复同样的实验时,这种影响就消失了。结论:我们确定了内移植物诱导的主动脉僵硬梯度是炎症性主动脉重塑过程的早期触发因素,可能会促进AND。这些结果强调了适当的内移植物设计的重要性,以尽量减少血管僵硬梯度和预防晚期并发症,如and。临床影响:AND可能影响血管内主动脉修复后的长期结果。然而,潜在的有害主动脉重构背后的机制仍不清楚。在这项研究中,我们发现内移植诱导的主动脉僵硬梯度诱导了与AND一致的炎症性主动脉重塑反应。这一新颖的病理力学见解可以指导新的主动脉内移植物的设计,从而最大限度地减少血管僵硬梯度并预防晚期并发症,如and。
{"title":"Abdominal Aortic Endograft Implantation Immediately Induces Vascular Stiffness Gradients That May Promote Adverse Aortic Neck Dilatation: Results of A Porcine <i>Ex Vivo</i> Study.","authors":"Isabel N Schellinger, Jörg Naumann, Annett Hoffmann, Sarah-Jane Barnard, Sandra Düsing, Markus U Wagenhäuser, Josephina Haunschild, Dierk Scheinert, Gerd Hasenfuß, Christian D Etz, Uwe Raaz","doi":"10.1177/15266028231169178","DOIUrl":"10.1177/15266028231169178","url":null,"abstract":"<p><strong>Purpose: </strong>Endovascular aortic repair (EVAR) is the method of choice for most abdominal aortic aneurysm (AAA) patients requiring intervention. However, chronic aortic neck dilatation (AND) following EVAR progressively weakens the structural seal between vessel and endograft and compromises long-term results of the therapy. This experimental <i>ex vivo</i> study seeks to investigate mechanisms of AND.</p><p><strong>Materials and methods: </strong>Porcine abdominal aortas (n=20) were harvested from slaughterhouse pigs and connected to a mock circulation. A commercially available endograft was implanted (n=10) or aortas were left untreated as controls (n=10). Vascular circumferential strain was assessed via ultrasound in defined aortic segments as a parameter of aortic stiffness. Histology and aortic gene expression analysis were performed to investigate potential changes of aortic wall structure and molecular differences due to endograft implantation.</p><p><strong>Results: </strong>We found that endograft implantation acutely induces a significant stiffness gradient directly at the interface between stented and unstented aortic segments under pulsatile pressure. Comparing stented aortas with unstented controls, we detected increased aortic expression levels of inflammatory cytokines (<i>Il6</i> and <i>Ccl2</i>) and matrix metalloproteinases (<i>Mmp2</i> and <i>Mmp9</i>) after 6 hours of pulsatile pressurization. This effect, however, was abolished when repeating the same experiment under 6 hours of static pressure.</p><p><strong>Conclusions: </strong>We identified endograft-induced aortic stiffness gradients as an early trigger of inflammatory aortic remodeling processes that might promote AND. These results highlight the importance of adequate endograft designs to minimize vascular stiffness gradients and forestall late complications, such as AND.</p><p><strong>Clinical impact: </strong>AND may compromise the long-term results following endovascular aortic repair. However, the mechanisms behind the underlying detrimental aortic remodeling are still unclear. In this study we find that endograft-induced aortic stiffness gradients induce an inflammatory aortic remodeling response consistent with AND. This novel pathomechanistic insight may guide the design of new aortic endografts that minimize vascular stiffness gradients and forestall late complications such as AND.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"242-250"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707956/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9437033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing Endovascular Aneurysm Repair Suitability According to Graft-Specific Instructions for Use in Patients With a Ruptured Abdominal Aortic Aneurysm. 根据腹主动脉瘤破裂患者移植特异性指导评估血管内动脉瘤修复的适用性。
IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 Epub Date: 2023-04-25 DOI: 10.1177/15266028231169180
Bergin Gjosha, Gert Jan Boer, Bram Fioole, M G Buimer, Jorg L de Bruin, Arnela Suman, Lijckle van der Laan

Purpose: The purpose of the study is to ascertain endovascular aneurysm repair (EVAR) suitability in relation to stent-graft-specific instructions for use (IFU) in patients with a ruptured abdominal aortic aneurysm (RAAA).

Materials and methods: Using the preoperative computed tomography angiography (CTA), the aortic morphology of patients undergoing surgical repair of a RAAA in 2 Dutch hospitals between January 2014 and December 2019 was retrospectively assessed. Three-dimensional and central luminal line reconstructions were used. Anatomical suitability was defined according to the IFU of the stent graft system used.

Results: Of 128 included patients, 112 (88%) were men and the mean age was 74.1 (SD=7.6) years. Anatomy within IFU for EVAR was present in 31 patients (24%). Overall, 94 patients (73%) were treated with open surgical repair (OSR) and 34 patients (27%) were treated with EVAR. Anatomy within IFU was present in 15 OSR patients (16%) and 16 EVAR patients (47%). In patients with anatomy outside of IFU, 90% (87/97) had unsuitable neck anatomy and 64% (62/97) had insufficient neck length. An unsuitable distal iliac landing zone was observed in 35 patients. Perioperative mortality was 27% (34/128), with no difference between OSR and EVAR (25/94 vs 9/34; p=0.989).

Conclusion: Most RAAA patients in this series did not have aortic anatomy within IFU for EVAR, mainly due to insufficient neck length. However, whether anatomy outside of IFU equates to unsuitability for EVAR in an emergency setting remains a matter of debate and warrants further research.

Clinical impact: The treatment of a ruptured abdominal aortic aneurysm can consist of endovascular repair or open repair. Retrospective anatomical assessment shows that most patients do not have anatomy inside the instructions for use for endovascular aneurysm repair, mainly due to insufficient neck length. Whether anatomy outside the instructions for use equates unsuitability for endovascular aneurysm repair remains a matter of debate.

目的:本研究的目的是确定血管内动脉瘤修复(EVAR)在腹主动脉瘤破裂(RAAA)患者中与支架移植特异性使用指南(IFU)相关的适用性。材料和方法:采用术前计算机断层血管造影(CTA),回顾性评估2014年1月至2019年12月在荷兰2家医院接受RAAA手术修复的患者的主动脉形态。采用三维和中央腔线重建。根据所使用支架移植系统的IFU定义解剖适宜性。结果:纳入的128例患者中,男性112例(88%),平均年龄74.1岁(SD=7.6)。31例(24%)患者在IFU内进行EVAR解剖。总体而言,94例(73%)患者接受了开放式手术修复(OSR)治疗,34例(27%)患者接受了EVAR治疗。15例OSR患者(16%)和16例EVAR患者(47%)存在IFU内解剖。在IFU以外解剖结构的患者中,90%(87/97)的颈部解剖不合适,64%(62/97)的颈部长度不足。35例患者髂远端着陆点不合适。围手术期死亡率为27% (34/128),OSR和EVAR之间无差异(25/94 vs 9/34;p = 0.989)。结论:本系列大多数RAAA患者在IFU内未进行EVAR的主动脉解剖,主要原因是颈长不足。然而,在紧急情况下,IFU以外的解剖结构是否等同于不适合进行EVAR仍然存在争议,需要进一步研究。临床影响:腹主动脉瘤破裂的治疗包括血管内修复或切开修复。回顾性解剖评估显示,大多数患者没有血管内动脉瘤修复使用说明书内的解剖资料,主要原因是颈部长度不够。使用说明书以外的解剖结构是否等同于不适合血管内动脉瘤修复仍然是一个有争议的问题。
{"title":"Assessing Endovascular Aneurysm Repair Suitability According to Graft-Specific Instructions for Use in Patients With a Ruptured Abdominal Aortic Aneurysm.","authors":"Bergin Gjosha, Gert Jan Boer, Bram Fioole, M G Buimer, Jorg L de Bruin, Arnela Suman, Lijckle van der Laan","doi":"10.1177/15266028231169180","DOIUrl":"10.1177/15266028231169180","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of the study is to ascertain endovascular aneurysm repair (EVAR) suitability in relation to stent-graft-specific instructions for use (IFU) in patients with a ruptured abdominal aortic aneurysm (RAAA).</p><p><strong>Materials and methods: </strong>Using the preoperative computed tomography angiography (CTA), the aortic morphology of patients undergoing surgical repair of a RAAA in 2 Dutch hospitals between January 2014 and December 2019 was retrospectively assessed. Three-dimensional and central luminal line reconstructions were used. Anatomical suitability was defined according to the IFU of the stent graft system used.</p><p><strong>Results: </strong>Of 128 included patients, 112 (88%) were men and the mean age was 74.1 (SD=7.6) years. Anatomy within IFU for EVAR was present in 31 patients (24%). Overall, 94 patients (73%) were treated with open surgical repair (OSR) and 34 patients (27%) were treated with EVAR. Anatomy within IFU was present in 15 OSR patients (16%) and 16 EVAR patients (47%). In patients with anatomy outside of IFU, 90% (87/97) had unsuitable neck anatomy and 64% (62/97) had insufficient neck length. An unsuitable distal iliac landing zone was observed in 35 patients. Perioperative mortality was 27% (34/128), with no difference between OSR and EVAR (25/94 vs 9/34; p=0.989).</p><p><strong>Conclusion: </strong>Most RAAA patients in this series did not have aortic anatomy within IFU for EVAR, mainly due to insufficient neck length. However, whether anatomy outside of IFU equates to unsuitability for EVAR in an emergency setting remains a matter of debate and warrants further research.</p><p><strong>Clinical impact: </strong>The treatment of a ruptured abdominal aortic aneurysm can consist of endovascular repair or open repair. Retrospective anatomical assessment shows that most patients do not have anatomy inside the instructions for use for endovascular aneurysm repair, mainly due to insufficient neck length. Whether anatomy outside the instructions for use equates unsuitability for endovascular aneurysm repair remains a matter of debate.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"100-109"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9447879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Proximal Landing Zone 1 and 2 Thoracic Endovascular Aortic Repair for Type B Aortic Dissection by Comparing Outcomes With Thoracic Arch Aneurysm. 近端着陆区1和2胸主动脉腔内修复治疗B型主动脉夹层与胸弓动脉瘤疗效比较
IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 Epub Date: 2023-05-24 DOI: 10.1177/15266028231174407
Tomoaki Kudo, Toru Kuratani, Yoshiki Sawa, Shigeru Miyagawa

Purpose: Hybrid thoracic endovascular aortic repair (TEVAR) for aortic arch aneurysms is a minimally invasive procedure with improved results. This study aimed to clarify the effectiveness and expand the possibilities of zone 1 and 2 landing TEVAR for type B aortic dissection (TBAD) using our treatment strategy.

Methods: This retrospective, single-center, observational cohort study included 213 patients (TBAD, n=69; thoracic arch aneurysm [TAA], n=144; median age, 72 years; median follow-up period, 6 years) from May 2008 to February 2020. The following conditions were satisfied before performing zone 1 and 2 landing TEVAR: TBAD; proximal landing zone (LZ): diameter <37 mm, length >15 mm, and nondissection area, proximal stent-graft: size ≤40 mm and oversizing rate: 10% to 20%, and TAA; proximal LZ: diameter ≤42 mm and length >15 mm, proximal stent-graft: size ≤46 mm and oversizing rate: 10% to 20%. Of the 69 patients in the TBAD group, 34 (49.3%) had patent false lumen (PFL), and 35 (50.7%) had false lumen partial thrombosis (FLPT), including ulcer-like projections. Emergency procedures were performed in 33 (15.5%) patients.

Results: There were no significant differences in the in-hospital mortality (TBAD: 1.5% vs TAA: 0.7%, p=0.544) or the in-hospital aortic complications (TBAD: n=1 vs TAA: n=5, p=0.666). Retrograde type A dissection was not observed in the TBAD group. The aortic event-free rates at 10 years were 89.7% (95% confidence interval [CI]: 78.7%-95.3%) and 87.9% (95% CI: 80.3%-92.8%) in the TBAD and TAA groups, respectively (log-rank p=0.636). In the TBAD group, the early and late outcomes were not significantly different between the PFL and FLPT groups.

Conclusion: Satisfactory early and long-term results were obtained with zone 1 and 2 landing TEVAR. The TBAD cases had the same good results as the TAA cases. Using our strategy, we especially might reduce complications and be an effective treatment for acute complicated TBAD.

Clinical impact: This study aimed to clarify the effectiveness and expand the possibilities of zones 1 and 2 landing TEVAR for type B aortic dissection (TBAD) using our treatment strategy. Satisfactory early and long-term results in the TBAD and thoracic arch aneurysm (TAA) groups were obtained with zones 1 and 2 landing TEVAR. The TBAD cases had the same good results as the TAA cases. Using our strategy, we especially might reduce complications and be an effective treatment for acute complicated TBAD.

目的:混合胸血管内主动脉修复术(TEVAR)是一种微创手术,可改善主动脉弓动脉瘤的治疗效果。本研究旨在阐明使用我们的治疗策略对B型主动脉夹层(TBAD)进行1区和2区TEVAR着陆的有效性和可能性。方法:这项回顾性、单中心、观察性队列研究纳入213例TBAD患者(n=69;胸弓动脉瘤[TAA], n=144;平均年龄72岁;2008年5月至2020年2月的中位随访期为6年。在进行1区和2区着陆TEVAR前,需要满足以下条件:TBAD;近端支架植入区(LZ):直径15mm,非剥离区;近端支架移植:尺寸≤40mm,尺寸过大率:10% ~ 20%;近端LZ:直径≤42 mm,长度> 15mm,近端支架移植物:尺寸≤46 mm,超大率10% ~ 20%。在TBAD组的69例患者中,34例(49.3%)存在未闭假腔(PFL), 35例(50.7%)存在假腔部分血栓形成(FLPT),包括溃疡样突出。33例(15.5%)患者接受了急诊治疗。结果:两组住院死亡率(TBAD: 1.5% vs TAA: 0.7%, p=0.544)和住院主动脉并发症(TBAD: n=1 vs TAA: n=5, p=0.666)差异无统计学意义。TBAD组未见逆行性A型夹层。TBAD组和TAA组10年无主动脉事件发生率分别为89.7%(95%可信区间[CI]: 78.7%-95.3%)和87.9%(95%可信区间[CI]: 80.3%-92.8%) (log-rank p=0.636)。在TBAD组中,PFL组和FLPT组的早期和晚期预后无显著差异。结论:1区和2区TEVAR的早期和远期疗效满意。TBAD病例与TAA病例疗效相同。采用我们的策略,我们尤其可以减少并发症,是治疗急性复杂TBAD的有效方法。临床影响:本研究旨在阐明使用我们的治疗策略对B型主动脉夹层(TBAD)进行1区和2区TEVAR着陆的有效性和可能性。TBAD组和胸弓动脉瘤(TAA)组的1区和2区TEVAR均获得满意的早期和长期结果。TBAD病例与TAA病例疗效相同。采用我们的策略,我们尤其可以减少并发症,是治疗急性复杂TBAD的有效方法。
{"title":"Effectiveness of Proximal Landing Zone 1 and 2 Thoracic Endovascular Aortic Repair for Type B Aortic Dissection by Comparing Outcomes With Thoracic Arch Aneurysm.","authors":"Tomoaki Kudo, Toru Kuratani, Yoshiki Sawa, Shigeru Miyagawa","doi":"10.1177/15266028231174407","DOIUrl":"10.1177/15266028231174407","url":null,"abstract":"<p><strong>Purpose: </strong>Hybrid thoracic endovascular aortic repair (TEVAR) for aortic arch aneurysms is a minimally invasive procedure with improved results. This study aimed to clarify the effectiveness and expand the possibilities of zone 1 and 2 landing TEVAR for type B aortic dissection (TBAD) using our treatment strategy.</p><p><strong>Methods: </strong>This retrospective, single-center, observational cohort study included 213 patients (TBAD, n=69; thoracic arch aneurysm [TAA], n=144; median age, 72 years; median follow-up period, 6 years) from May 2008 to February 2020. The following conditions were satisfied before performing zone 1 and 2 landing TEVAR: TBAD; proximal landing zone (LZ): diameter <37 mm, length >15 mm, and nondissection area, proximal stent-graft: size ≤40 mm and oversizing rate: 10% to 20%, and TAA; proximal LZ: diameter ≤42 mm and length >15 mm, proximal stent-graft: size ≤46 mm and oversizing rate: 10% to 20%. Of the 69 patients in the TBAD group, 34 (49.3%) had patent false lumen (PFL), and 35 (50.7%) had false lumen partial thrombosis (FLPT), including ulcer-like projections. Emergency procedures were performed in 33 (15.5%) patients.</p><p><strong>Results: </strong>There were no significant differences in the in-hospital mortality (TBAD: 1.5% vs TAA: 0.7%, p=0.544) or the in-hospital aortic complications (TBAD: n=1 vs TAA: n=5, p=0.666). Retrograde type A dissection was not observed in the TBAD group. The aortic event-free rates at 10 years were 89.7% (95% confidence interval [CI]: 78.7%-95.3%) and 87.9% (95% CI: 80.3%-92.8%) in the TBAD and TAA groups, respectively (log-rank p=0.636). In the TBAD group, the early and late outcomes were not significantly different between the PFL and FLPT groups.</p><p><strong>Conclusion: </strong>Satisfactory early and long-term results were obtained with zone 1 and 2 landing TEVAR. The TBAD cases had the same good results as the TAA cases. Using our strategy, we especially might reduce complications and be an effective treatment for acute complicated TBAD.</p><p><strong>Clinical impact: </strong>This study aimed to clarify the effectiveness and expand the possibilities of zones 1 and 2 landing TEVAR for type B aortic dissection (TBAD) using our treatment strategy. Satisfactory early and long-term results in the TBAD and thoracic arch aneurysm (TAA) groups were obtained with zones 1 and 2 landing TEVAR. The TBAD cases had the same good results as the TAA cases. Using our strategy, we especially might reduce complications and be an effective treatment for acute complicated TBAD.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"170-184"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9512774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Outcomes of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique in Patients With Aorto-Iliac Occlusive Disease. 覆盖血管内主动脉分叉重建(CERAB)技术在主动脉-髂闭塞性疾病患者中的长期疗效
IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 Epub Date: 2023-04-28 DOI: 10.1177/15266028231166539
Kaj B Rouwenhorst, Omar M A Abdelbaqy, Daphne van der Veen, Rianne E van Rijswijk, Suzanne Holewijn, Michel M P J Reijnen
<p><strong>Background: </strong>The Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) reconstruction is an endovascular technique, developed to reconstruct the aortic bifurcation in the most optimal anatomical and physiological manner. Short-term data were promising, but long-term data are still lacking. The objective was to report the long-term outcomes of CERAB for extensive aorto-iliac occlusive disease and to identify predictors for loss of primary patency.</p><p><strong>Methods: </strong>Consecutive electively treated patients with CERAB for aorto-iliac occlusive disease in a single hospital were identified and analyzed. Baseline and procedural data and follow-up were collected at 6-weeks, 6 months, 12 months, and annually thereafter. Technical success, procedural, and 30-day complications were evaluated, as well as overall survival. Patency and freedom from target lesion revascularization rates were analyzed using Kaplan Meier curves. Uni- and multivariate analysis were performed to identify possible predictors of failure.</p><p><strong>Results: </strong>One hundred and sixty patients were included (79 male). Indication for treatment was intermittent claudication for 121 patients (75.6%) and 133 patients (83.1%) had a TASC-II D lesion. Technical success was obtained in 95.6% of patients and the 30-day mortality rate was 1.3%. The 5-year primary, primary-assisted, and secondary patency rates were 77.5%, 88.1%, and 95.0%, respectively, with a freedom-from clinically driven target lesion revascularization (CD-TLR) rate of 84.4%. The strongest predictor of loss of primary patency of CERAB was a previous aorto-iliac intervention (odds ratio [OR]=5.36 (95% confidence interval [CI]: 1.30; 22.07), p=0.020). In patients not previously treated in the aorto-iliac tract, 5-year primary, primary assisted, and secondary patency rates were 85.1%, 94.4%, and 96.9%, respectively. At 5-year follow-up, an improved Rutherford was found in 97.9% of patients and the freedom from major amputation rate was 100%.</p><p><strong>Conclusion: </strong>The CERAB technique is related to good long-term outcomes, particularly in primary cases. In patients that had prior treatment for aorto-iliac occlusive disease, there were more reinterventions and therefore surveillance should likely be more intense.</p><p><strong>Clinical impact: </strong>The Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) reconstruction was designed to improve outcomes of endovascular treatment of extensive aorto-iliac occlusive disease. At 5-year follow-up clinical improvement was found in 97.9% of patients without major amputations. The 5-year overall primary, primary-assisted, and secondary patency rates were 77.5%, 88.1%, and 95.0%, respectively, with a freedom-from clinically driven target lesion revascularization rate of 84.4%. Significantly better patency rates were observed for patients that were never treated before in the target area. The data implica
背景:主动脉分叉覆盖血管内重建(CERAB)是一种血管内重建技术,旨在以最佳的解剖和生理方式重建主动脉分叉。短期数据令人鼓舞,但长期数据仍然缺乏。目的是报告CERAB治疗广泛主动脉-髂闭塞性疾病的长期结果,并确定原发性通畅丧失的预测因素。方法:对同一医院连续选择性接受CERAB治疗的主动脉-髂闭塞性疾病患者进行鉴定和分析。在6周、6个月、12个月和此后每年收集基线和程序数据及随访。评估技术成功、手术、30天并发症以及总生存期。用Kaplan Meier曲线分析通畅和不受目标病变影响的血运重建率。进行单因素和多因素分析以确定可能的失败预测因素。结果:共纳入160例患者,其中男性79例。121例(75.6%)患者的治疗指征为间歇性跛行,133例(83.1%)患者有TASC-II D病变。技术成功率为95.6%,30天死亡率为1.3%。5年原发性、原发性辅助和继发性通畅率分别为77.5%、88.1%和95.0%,临床驱动的靶病变血运重建率(CD-TLR)为84.4%。CERAB原发性通畅丧失的最强预测因子是先前的主动脉-髂动脉干预(优势比[OR]=5.36(95%可信区间[CI]: 1.30;22.07), p = 0.020)。在先前未接受过主动脉-髂道治疗的患者中,5年原发性、原发性辅助和继发性通畅率分别为85.1%、94.4%和96.9%。5年随访,97.9%的患者卢瑟福改善,大截肢率100%。结论:CERAB技术具有良好的长期预后,特别是在原发性病例中。在先前接受过主动脉-髂闭塞性疾病治疗的患者中,有更多的再干预,因此监测可能应该更强烈。临床影响:有盖主动脉分叉血管内重建(CERAB)旨在改善广泛主动脉-髂闭塞性疾病的血管内治疗效果。在5年随访中,97.9%的未截肢患者临床改善。5年总体原发性、原发性辅助和继发性通畅率分别为77.5%、88.1%和95.0%,临床驱动的靶病变血运重建率为84.4%。对于以前从未在靶区接受过治疗的患者,观察到明显更好的通畅率。数据表明,CERAB是广泛主动脉-髂闭塞性疾病患者的有效治疗选择。对于以前在目标地区接受过治疗的患者,可以考虑其他治疗方案,或者有必要进行更密切的随访监测。
{"title":"Long-Term Outcomes of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique in Patients With Aorto-Iliac Occlusive Disease.","authors":"Kaj B Rouwenhorst, Omar M A Abdelbaqy, Daphne van der Veen, Rianne E van Rijswijk, Suzanne Holewijn, Michel M P J Reijnen","doi":"10.1177/15266028231166539","DOIUrl":"10.1177/15266028231166539","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) reconstruction is an endovascular technique, developed to reconstruct the aortic bifurcation in the most optimal anatomical and physiological manner. Short-term data were promising, but long-term data are still lacking. The objective was to report the long-term outcomes of CERAB for extensive aorto-iliac occlusive disease and to identify predictors for loss of primary patency.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Consecutive electively treated patients with CERAB for aorto-iliac occlusive disease in a single hospital were identified and analyzed. Baseline and procedural data and follow-up were collected at 6-weeks, 6 months, 12 months, and annually thereafter. Technical success, procedural, and 30-day complications were evaluated, as well as overall survival. Patency and freedom from target lesion revascularization rates were analyzed using Kaplan Meier curves. Uni- and multivariate analysis were performed to identify possible predictors of failure.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;One hundred and sixty patients were included (79 male). Indication for treatment was intermittent claudication for 121 patients (75.6%) and 133 patients (83.1%) had a TASC-II D lesion. Technical success was obtained in 95.6% of patients and the 30-day mortality rate was 1.3%. The 5-year primary, primary-assisted, and secondary patency rates were 77.5%, 88.1%, and 95.0%, respectively, with a freedom-from clinically driven target lesion revascularization (CD-TLR) rate of 84.4%. The strongest predictor of loss of primary patency of CERAB was a previous aorto-iliac intervention (odds ratio [OR]=5.36 (95% confidence interval [CI]: 1.30; 22.07), p=0.020). In patients not previously treated in the aorto-iliac tract, 5-year primary, primary assisted, and secondary patency rates were 85.1%, 94.4%, and 96.9%, respectively. At 5-year follow-up, an improved Rutherford was found in 97.9% of patients and the freedom from major amputation rate was 100%.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The CERAB technique is related to good long-term outcomes, particularly in primary cases. In patients that had prior treatment for aorto-iliac occlusive disease, there were more reinterventions and therefore surveillance should likely be more intense.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Clinical impact: &lt;/strong&gt;The Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) reconstruction was designed to improve outcomes of endovascular treatment of extensive aorto-iliac occlusive disease. At 5-year follow-up clinical improvement was found in 97.9% of patients without major amputations. The 5-year overall primary, primary-assisted, and secondary patency rates were 77.5%, 88.1%, and 95.0%, respectively, with a freedom-from clinically driven target lesion revascularization rate of 84.4%. Significantly better patency rates were observed for patients that were never treated before in the target area. The data implica","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"110-120"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9726806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous Superficial Temporal Artery Access Facilitating Carotid Artery Stenting Performed From Distal Radial Artery. 经皮颞浅动脉通路促进桡动脉远端行颈动脉支架置入。
IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 Epub Date: 2023-03-30 DOI: 10.1177/15266028231163440
Peter Hausinger, Gellerd Markos-Gergely, Tamas Nemeth, Pal Barzo

Purpose: The purpose of the study is to describe carotid artery stenting (CAS) via distal transradial access (dTRA) facilitated by additional superficial temporal artery (STA) access, in a patient with complex aortic arch vessel anatomy.

Technique: A 72-year-old woman with a prior history of complex cervical surgery and radiotherapy due to laryngeal malignancy, presented with a symptomatic 90% stenosis of the left internal carotid artery (ICA). Due to high cervical lesion, the patient was rejected from carotid endarterectomy. Angiography demonstrated 90% stenosis of the left ICA and a type III aortic arch. After failure of left common carotid artery (CCA) cannulation with appropriate catheter support via dTRA and transfemoral approaches, CAS was attempted a second time. After percutaneous ultrasound guided access to right dTRA and left STA, a 0.035 inch guidewire introduced to the left CCA from the contralateral dTRA was snared and externalized via left STA to improve wire support for guiding advancement. Thereafter, the left ICA lesion was successfully stented with a 7×30 mm self-expanding stent via right dTRA. All vessels involved were patent at 6-month follow-up.

Conclusion: The STA may be a promising adjunctive access site to increase transradial catheter support for CAS or neurointerventional procedures in the anterior circulation.

Clinical impact: Transradial cerebrovascular interventions have been gaining popularity, however, unstable catheter access to distal cerebrovascular structures limits its widespread use. Guidewire externalization technique via additional STA access may improve transradial catheter stabilty and increase procedural success with possibly low access stie complication rate.

目的:本研究的目的是描述在主动脉弓血管解剖复杂的患者中,通过远端经桡动脉通路(dTRA)和额外的颞浅动脉(STA)通路促进颈动脉支架植入术(CAS)。技术:一名72岁的女性,既往因喉恶性肿瘤接受过复杂的颈椎手术和放疗,表现为左侧颈内动脉(ICA) 90%狭窄的症状。由于颈椎病变程度高,患者拒绝行颈动脉内膜切除术。血管造影显示左侧ICA狭窄90%,主动脉弓为III型。经dTRA和经股入路给予适当导管支持的左颈总动脉插管失败后,再次尝试行颈总动脉插管。经皮超声引导进入右侧dTRA和左侧STA后,从对侧dTRA引入一根0.035英寸的导丝,并通过左侧STA引入左侧CCA,以改善导丝对引导推进的支持。随后,通过右侧dTRA使用7×30 mm自膨胀支架成功置入左侧ICA病变。随访6个月,所有受累血管均通畅。结论:STA可能是一种很有前途的辅助通路,可以增加经桡动脉导管对CAS或前循环神经介入手术的支持。临床影响:经桡动脉脑血管介入治疗越来越受欢迎,然而,导管进入远端脑血管结构的不稳定限制了其广泛应用。通过额外STA通路的导丝外化技术可以提高经桡动脉导管的稳定性,增加手术成功率,并可能降低通路并发症发生率。
{"title":"Percutaneous Superficial Temporal Artery Access Facilitating Carotid Artery Stenting Performed From Distal Radial Artery.","authors":"Peter Hausinger, Gellerd Markos-Gergely, Tamas Nemeth, Pal Barzo","doi":"10.1177/15266028231163440","DOIUrl":"10.1177/15266028231163440","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of the study is to describe carotid artery stenting (CAS) via distal transradial access (dTRA) facilitated by additional superficial temporal artery (STA) access, in a patient with complex aortic arch vessel anatomy.</p><p><strong>Technique: </strong>A 72-year-old woman with a prior history of complex cervical surgery and radiotherapy due to laryngeal malignancy, presented with a symptomatic 90% stenosis of the left internal carotid artery (ICA). Due to high cervical lesion, the patient was rejected from carotid endarterectomy. Angiography demonstrated 90% stenosis of the left ICA and a type III aortic arch. After failure of left common carotid artery (CCA) cannulation with appropriate catheter support via dTRA and transfemoral approaches, CAS was attempted a second time. After percutaneous ultrasound guided access to right dTRA and left STA, a 0.035 inch guidewire introduced to the left CCA from the contralateral dTRA was snared and externalized via left STA to improve wire support for guiding advancement. Thereafter, the left ICA lesion was successfully stented with a 7×30 mm self-expanding stent via right dTRA. All vessels involved were patent at 6-month follow-up.</p><p><strong>Conclusion: </strong>The STA may be a promising adjunctive access site to increase transradial catheter support for CAS or neurointerventional procedures in the anterior circulation.</p><p><strong>Clinical impact: </strong>Transradial cerebrovascular interventions have been gaining popularity, however, unstable catheter access to distal cerebrovascular structures limits its widespread use. Guidewire externalization technique via additional STA access may improve transradial catheter stabilty and increase procedural success with possibly low access stie complication rate.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"29-33"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9210361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initial Clinical Experience With AneuFix Injectable Biocompatible Elastomer for Translumbar Embolization of Type 2 Endoleaks. AneuFix可注射生物相容性弹性体用于2型腰椎内漏栓塞的初步临床经验。
IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 Epub Date: 2023-04-19 DOI: 10.1177/15266028231165731
Stefan P M Smorenburg, Rutger J Lely, Bas-Jeroen van Kelckhoven, Erik G Vermeulen, Kak Khee Yeung, Rombout R Kruse, Martin Kraai, Chrit M Stassen, Michael J Jacobs, Arjan W J Hoksbergen
<p><strong>Purpose: </strong>The aim of this study was to assess the initial experience, technical success, and clinical benefit of AneuFix (TripleMed, Geleen, the Netherlands), a novel biocompatible and non-inflammatory elastomer that is directly injected into the aneurysm sac by a translumbar puncture in patients with a type II endoleak and a growing aneurysm.</p><p><strong>Materials and methods: </strong>A multicenter, prospective, pivotal study was conducted (ClinicalTrials.gov:NCT02487290). Patients with a type II endoleak and aneurysm growth (>5 mm) were included. Patients with a patent inferior mesenteric artery connected to the endoleak were excluded for initial safety reasons. The endoleak cavity was translumbar punctured with cone-beam computed tomography (CT) and software guidance. Angiography of the endoleak was performed, all lumbar arteries connected to the endoleak were visualized, and AneuFix elastomer was injected into the endoleak cavity and short segment of the lumbar arteries. The primary endpoint was technical success, defined as successful filling of the endoleak cavity with computed tomography angiography (CTA) assessment within 24 hours. Secondary endpoints were clinical success defined as the absence of abdominal aortic aneurysm (AAA) growth at 6 months on CTA, serious adverse events, re-interventions, and neurological abnormalities. Computed tomography angiography follow-up was performed at 1 day and at 3, 6, and 12 months. This analysis reports the initial experience of the first 10 patients treated with AneuFix.</p><p><strong>Results: </strong>Seven men and 3 women with a median age of 78 years (interquartile range (IQR), 74-84) were treated. Median aneurysm growth after endovascular aneurysm repair (EVAR) was 19 mm (IQR, 8-23 mm). Technical success was 100%; it was possible to puncture the endoleak cavity of all treated patients and to inject AneuFix. Clinical success at 6 months was 90%. One patient showed 5 mm growth with persisting endoleak, probably due to insufficient endoleak filling. No serious adverse events related to the procedure or AneuFix material were reported. No neurological disorders were reported.</p><p><strong>Conclusion: </strong>The first results of type II endoleak treatment with AneuFix injectable elastomer in a small number of patients with a growing aneurysm show that it is technically feasible, safe, and clinically effective at 6 months.</p><p><strong>Clinical impact: </strong>Effective and durable embolization of type II endoleaks causing abdominal aortic aneurysms (AAA) growth after EVAR is challenging. A novel injectable elastic polymer (elastomer) was developed, specifically designed to treat type II endoleaks (AneuFix, TripleMed, Geleen, the Netherlands). Embolization of the type II endoleak was performed by translumbar puncture. The viscosity changes from paste-like during injection, into an elastic implant after curing. The initial experience of this multicentre prospective pivotal tri
目的:本研究的目的是评估AneuFix (TripleMed, Geleen, Netherlands)的初步经验、技术成功和临床效益。AneuFix是一种新型的生物相容性和非炎性弹性体,通过经腰椎穿刺直接注射到II型内漏和生长中的动脉瘤囊中。材料和方法:进行了一项多中心、前瞻性、关键研究(ClinicalTrials.gov:NCT02487290)。包括II型内漏和动脉瘤生长(bbb50 mm)的患者。由于最初的安全原因,肠系膜下动脉未闭连接内漏的患者被排除在外。采用锥束计算机断层扫描(CT)和软件引导,经腰椎穿刺漏腔。对漏腔进行血管造影,观察与漏腔相连的所有腰椎动脉,将AneuFix弹性体注入漏腔和短段腰椎动脉。主要终点是技术成功,定义为在24小时内通过计算机断层血管造影(CTA)评估成功填充漏腔。次要终点是临床成功,定义为在CTA上6个月没有腹主动脉瘤(AAA)生长,严重不良事件,再干预和神经异常。分别于第1天、第3、6、12个月进行计算机断层血管造影随访。本分析报告了前10名接受AneuFix治疗的患者的初步经验。结果:7名男性,3名女性,中位年龄78岁(四分位间距(IQR), 74-84)。血管内动脉瘤修复(EVAR)后正中动脉瘤生长19 mm (IQR, 8-23 mm)。技术成功率100%;所有治疗的患者均可穿刺内漏腔并注射AneuFix。6个月的临床成功率为90%。1例患者显示5毫米的生长并持续的内漏,可能是由于内漏填充不足。未报告与手术或AneuFix材料相关的严重不良事件。无神经系统疾病的报道。结论:AneuFix可注射弹性体治疗II型动脉瘤患者的初步结果表明,该方法在6个月时技术上可行、安全且临床有效。临床影响:有效和持久的栓塞II型内漏导致腹主动脉瘤(AAA)在EVAR后生长是具有挑战性的。一种新型的可注射弹性聚合物(弹性体)被开发出来,专门用于治疗II型内漏(AneuFix, TripleMed, Geleen,荷兰)。经腰椎穿刺栓塞II型内漏。黏度由注射时的糊状变为固化后的弹性植入物。这项多中心前瞻性关键试验的初步经验表明,该手术是可行和安全的,技术成功率为100%。治疗6个月时,10例患者中有9例未见AAA生长。
{"title":"Initial Clinical Experience With AneuFix Injectable Biocompatible Elastomer for Translumbar Embolization of Type 2 Endoleaks.","authors":"Stefan P M Smorenburg, Rutger J Lely, Bas-Jeroen van Kelckhoven, Erik G Vermeulen, Kak Khee Yeung, Rombout R Kruse, Martin Kraai, Chrit M Stassen, Michael J Jacobs, Arjan W J Hoksbergen","doi":"10.1177/15266028231165731","DOIUrl":"10.1177/15266028231165731","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;The aim of this study was to assess the initial experience, technical success, and clinical benefit of AneuFix (TripleMed, Geleen, the Netherlands), a novel biocompatible and non-inflammatory elastomer that is directly injected into the aneurysm sac by a translumbar puncture in patients with a type II endoleak and a growing aneurysm.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;A multicenter, prospective, pivotal study was conducted (ClinicalTrials.gov:NCT02487290). Patients with a type II endoleak and aneurysm growth (&gt;5 mm) were included. Patients with a patent inferior mesenteric artery connected to the endoleak were excluded for initial safety reasons. The endoleak cavity was translumbar punctured with cone-beam computed tomography (CT) and software guidance. Angiography of the endoleak was performed, all lumbar arteries connected to the endoleak were visualized, and AneuFix elastomer was injected into the endoleak cavity and short segment of the lumbar arteries. The primary endpoint was technical success, defined as successful filling of the endoleak cavity with computed tomography angiography (CTA) assessment within 24 hours. Secondary endpoints were clinical success defined as the absence of abdominal aortic aneurysm (AAA) growth at 6 months on CTA, serious adverse events, re-interventions, and neurological abnormalities. Computed tomography angiography follow-up was performed at 1 day and at 3, 6, and 12 months. This analysis reports the initial experience of the first 10 patients treated with AneuFix.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Seven men and 3 women with a median age of 78 years (interquartile range (IQR), 74-84) were treated. Median aneurysm growth after endovascular aneurysm repair (EVAR) was 19 mm (IQR, 8-23 mm). Technical success was 100%; it was possible to puncture the endoleak cavity of all treated patients and to inject AneuFix. Clinical success at 6 months was 90%. One patient showed 5 mm growth with persisting endoleak, probably due to insufficient endoleak filling. No serious adverse events related to the procedure or AneuFix material were reported. No neurological disorders were reported.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The first results of type II endoleak treatment with AneuFix injectable elastomer in a small number of patients with a growing aneurysm show that it is technically feasible, safe, and clinically effective at 6 months.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Clinical impact: &lt;/strong&gt;Effective and durable embolization of type II endoleaks causing abdominal aortic aneurysms (AAA) growth after EVAR is challenging. A novel injectable elastic polymer (elastomer) was developed, specifically designed to treat type II endoleaks (AneuFix, TripleMed, Geleen, the Netherlands). Embolization of the type II endoleak was performed by translumbar puncture. The viscosity changes from paste-like during injection, into an elastic implant after curing. The initial experience of this multicentre prospective pivotal tri","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"57-67"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707960/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9383347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Objective Evaluation With Noncontrast Computed Tomography Can Reveal Calcified Plaque Solidity in Peripheral Artery Diseases. 目的非对比ct评价外周动脉病变钙化斑块的坚固性。
IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 Epub Date: 2023-05-02 DOI: 10.1177/15266028231170119
Dai Ozaki, Ken Yokoyama, Tetsuro Miyazaki, Koji Hirabayashi, Hiroshi Abe, Kosuke Yabe, Midori Kakihara, Masaaki Maki, Ryosuke Shimai, Hiroyuki Isogai, Shohei Ouchi, Yuki Yasuda, Fuminori Odagiri, Kazuhisa Takamura, Kenji Yaginuma, Takashi Tokano, Takashi Iwasaki, Satoru Kawai, Toru Minamino
<p><strong>Purpose: </strong>The presence of severely calcified plaque remains problematic in endovascular therapy, and no specific endovascular treatment strategy has been established. Estimating plaque solidity before the procedure may help operators penetrate calcified plaque with a guide wire. The aim of this study was to establish a method of measuring plaque solidity with noncontrast computed tomography (CT).</p><p><strong>Methods: </strong>This retrospective, single-center study included consecutive patients who, between October 2020 and July 2022, underwent noncontrast 5 mm and 1 mm CTs before endovascular therapy to penetrate calcified plaque with a wire in the common femoral, superficial femoral, and popliteal arteries. Three cross-sectional CT slices were selected. To target a calcified plaque lesion, the operator identified a region of interest, which corresponded to 24×24 pixels, and Hounsfield unit (HU) values of each pixel were displayed on the CT image. The average HU values and the ratio of number of pixels of lower values (130-599 HU) represented plaque solidity. We used the Mann-Whitney-Wilcoxon rank-sum test and the chi-square test to compare the solidity of plaques penetrated and not penetrated by the wire.</p><p><strong>Results: </strong>We evaluated 108 images of 36 calcified plaque lesions (in 19 patients). The wire penetrated 28 lesions (77.8%) successfully. The average HU value was significantly lower in the lesions that the wire penetrated than in the others, in both the 5 mm CT slices (434.7±86.8 HU vs 554.3±112.7 HU, p=0.0174) and 1 mm slices (497.8±103.1 HU vs 593.5±114.5 HU, p=0.0381). The receiver operating curve revealed that 529.9 and 533.9 HU in the 5 and 1 mm slices, respectively, were the highest values at which wires could penetrate. Moreover, at the lesions that were penetrates successfully, the ratio of number of lower HU value pixels was significantly higher both in 5 mm slice CTs (74.7±13.4 vs 61.7±13.1%, p=0.0347) and 1 mm (68.7±11.8 vs 57.1±11.4%, p=0.0174).</p><p><strong>Conclusion: </strong>The use of noncontrast CT to evaluate plaque solidity was associated with successful wire penetration of calcified lesions in peripheral arteries.</p><p><strong>Clinical impact: </strong>This study revealed an association between the wire penetration inside calcified plaque and plaque solidity estimated using non-contrasted computed tomography. The mean Hounsfield unit values of three cross-sections in calcified plaques were associated with the successful wire penetration. This wire penetration difficulty is associated with extended procedure time, excessive radiation exposure, usage of extra contrast agents, and increased medical costs. Therefore, estimating calcified plaque solidity before procedure enables us to choose effective and lean procedures. In addition, to predict the success of dilating calcified plaque from the inside is also beneficial when the operator wants to avoid extra scaffold implantation for
目的:严重钙化斑块的存在在血管内治疗中仍是一个问题,目前尚未建立特异性的血管内治疗策略。在手术前估计斑块的硬度可以帮助操作人员用导丝穿透钙化斑块。本研究的目的是建立一种用非对比计算机断层扫描(CT)测量斑块固体度的方法。方法:这项回顾性的单中心研究纳入了连续的患者,这些患者在2020年10月至2022年7月期间接受了5毫米和1毫米的非对比ct,然后在股总动脉、股浅动脉和腘动脉进行血管内治疗,以穿透钙化斑块。选择3张横切面CT切片。为了定位钙化斑块病变,操作员确定了一个感兴趣的区域,该区域对应于24×24像素,并在CT图像上显示每个像素的Hounsfield单位(HU)值。平均HU值和较低值像素数之比(130-599 HU)代表斑块的坚固性。我们使用Mann-Whitney-Wilcoxon秩和检验和卡方检验来比较金属丝穿透和未穿透的斑块的坚固性。结果:我们评估了108张36个钙化斑块病变的图像(19例患者)。导线成功穿透病灶28处(77.8%)。在5 mm CT片上(434.7±86.8 HU vs 554.3±112.7 HU, p=0.0174)和1 mm CT片上(497.8±103.1 HU vs 593.5±114.5 HU, p=0.0381),导线穿透病变的平均HU值明显低于其他病变。接收器工作曲线显示,529.9和533.9 HU分别是5和1 mm切片中线能穿透的最高值。此外,在成功穿透的病变中,5 mm ct(74.7±13.4 vs 61.7±13.1%,p=0.0347)和1 mm ct(68.7±11.8 vs 57.1±11.4%,p=0.0174)的低HU值像素数比例均显著高于5 mm ct(74.7±13.4 vs 61.7±13.1%,p=0.0347)。结论:使用非对比CT评估斑块的坚固性与外周动脉钙化病变的钢丝穿透成功相关。临床影响:本研究揭示了金属丝在钙化斑块内的穿透力与使用非对比计算机断层扫描估计的斑块坚固度之间的关系。钙化斑块的三个横截面的平均Hounsfield单位值与导线成功穿透有关。这种导线穿透困难与手术时间延长、过度辐射暴露、使用额外的造影剂和增加的医疗费用有关。因此,在手术前评估钙化斑块的坚固性使我们能够选择有效和精简的手术。此外,从内部预测钙化斑块扩张的成功也是有益的,当操作者希望避免额外的支架植入目标病变。
{"title":"Objective Evaluation With Noncontrast Computed Tomography Can Reveal Calcified Plaque Solidity in Peripheral Artery Diseases.","authors":"Dai Ozaki, Ken Yokoyama, Tetsuro Miyazaki, Koji Hirabayashi, Hiroshi Abe, Kosuke Yabe, Midori Kakihara, Masaaki Maki, Ryosuke Shimai, Hiroyuki Isogai, Shohei Ouchi, Yuki Yasuda, Fuminori Odagiri, Kazuhisa Takamura, Kenji Yaginuma, Takashi Tokano, Takashi Iwasaki, Satoru Kawai, Toru Minamino","doi":"10.1177/15266028231170119","DOIUrl":"10.1177/15266028231170119","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;The presence of severely calcified plaque remains problematic in endovascular therapy, and no specific endovascular treatment strategy has been established. Estimating plaque solidity before the procedure may help operators penetrate calcified plaque with a guide wire. The aim of this study was to establish a method of measuring plaque solidity with noncontrast computed tomography (CT).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This retrospective, single-center study included consecutive patients who, between October 2020 and July 2022, underwent noncontrast 5 mm and 1 mm CTs before endovascular therapy to penetrate calcified plaque with a wire in the common femoral, superficial femoral, and popliteal arteries. Three cross-sectional CT slices were selected. To target a calcified plaque lesion, the operator identified a region of interest, which corresponded to 24×24 pixels, and Hounsfield unit (HU) values of each pixel were displayed on the CT image. The average HU values and the ratio of number of pixels of lower values (130-599 HU) represented plaque solidity. We used the Mann-Whitney-Wilcoxon rank-sum test and the chi-square test to compare the solidity of plaques penetrated and not penetrated by the wire.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;We evaluated 108 images of 36 calcified plaque lesions (in 19 patients). The wire penetrated 28 lesions (77.8%) successfully. The average HU value was significantly lower in the lesions that the wire penetrated than in the others, in both the 5 mm CT slices (434.7±86.8 HU vs 554.3±112.7 HU, p=0.0174) and 1 mm slices (497.8±103.1 HU vs 593.5±114.5 HU, p=0.0381). The receiver operating curve revealed that 529.9 and 533.9 HU in the 5 and 1 mm slices, respectively, were the highest values at which wires could penetrate. Moreover, at the lesions that were penetrates successfully, the ratio of number of lower HU value pixels was significantly higher both in 5 mm slice CTs (74.7±13.4 vs 61.7±13.1%, p=0.0347) and 1 mm (68.7±11.8 vs 57.1±11.4%, p=0.0174).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The use of noncontrast CT to evaluate plaque solidity was associated with successful wire penetration of calcified lesions in peripheral arteries.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Clinical impact: &lt;/strong&gt;This study revealed an association between the wire penetration inside calcified plaque and plaque solidity estimated using non-contrasted computed tomography. The mean Hounsfield unit values of three cross-sections in calcified plaques were associated with the successful wire penetration. This wire penetration difficulty is associated with extended procedure time, excessive radiation exposure, usage of extra contrast agents, and increased medical costs. Therefore, estimating calcified plaque solidity before procedure enables us to choose effective and lean procedures. In addition, to predict the success of dilating calcified plaque from the inside is also beneficial when the operator wants to avoid extra scaffold implantation for ","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"139-147"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9395282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initial Outcomes of Physician-Modified Inner Branched Endovascular Repair in High-Surgical-Risk Patients. 医师改良内支血管内修复术在高危手术患者中的初步效果。
IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 Epub Date: 2023-04-27 DOI: 10.1177/15266028231169183
Tsuyoshi Shibata, Yutaka Iba, Tomohiro Nakajima, Junji Nakazawa, Akihito Ohkawa, Itaru Hosaka, Ayaka Arihara, Shingo Tsushima, Keishi Ogura, Kenta Yoshikawa, Nobuyoshi Kawaharada

Purpose: To report the initial outcomes of physician-modified inner branched endovascular repair (PMiBEVAR) for pararenal aneurysms (PRAs), thoracoabdominal aortic aneurysms (TAAAs), and aortic arch aneurysms in high-surgical-risk patients.

Materials and methods: A total of 10 patients (6 men; median age, 83.0 years) treated using PMiBEVAR were enrolled in this retrospective, single-center study. All patients were at high surgical risk because of severe comorbidities (American Society of Anesthesiologists physical status score≥3 or emergency repair). End points were defined as technical success per patient and per vessel (successful deployment), clinical success (no endoleaks postoperatively), in-hospital death, and major adverse events.

Results: There were 3 PRAs, 4 TAAAs, and 3 aortic arch aneurysms with 12 renal-mesenteric arteries and 3 left subclavian arteries incorporated by inner branches. The technical success rate was 90.0% (9/10) per patient and 93.3% (14/15) per vessel. The clinical success rate was 90% (9/10). There were 2 in-hospital deaths, unrelated to aneurysms. Paraplegia and shower emboli occurred separately in 2 patients. Three patients experienced prolonged ventilation for 3 days after surgery. Aneurysm sac shrinkage occurred in 4 patients, and aneurysm size stabilized in 1 patient during follow-up, more than 6 months later. None of the patients required intervention.

Conclusion: PMiBEVAR is a feasible approach for treating complex aneurysms in high-surgical-risk patients. This technology may complement the existing technology in terms of improved anatomical adaptability, no time delay and practicability in many countries. However, long-term durability remains undetermined. Further large-scale and long-term studies are needed.

Clinical impact: This is the first clinical study to investigate outcomes of physician-modified inner branched endovascular repair (PMiBEVAR). PMiBEVAR for treating pararenal aneurysm, thoracoabdominal aortic aneurysm, or aortic arch aneurysm is a feasible procedure. This technology is likely to complement existing technology in terms of improved anatomical adaptability (compared to off-the-shelf devices), no time delay (compared to custom-made devices), and the potential to be performed in many countries. On the other hand, surgery time varied greatly depending on the case, suggesting a learning curve and the need for technological innovation to perform more consistent surgeries.

目的:报道医师改良的内分支血管内修复术(PMiBEVAR)治疗肾旁动脉瘤(PRAs)、胸腹主动脉瘤(TAAAs)和主动脉弓高危患者的初步疗效。材料与方法:共10例患者(男性6例;接受PMiBEVAR治疗的患者中位年龄为83.0岁,纳入了这项回顾性单中心研究。由于严重的合并症(美国麻醉医师协会身体状况评分≥3分或紧急修复),所有患者手术风险均较高。终点定义为每位患者和每根血管的技术成功(成功部署)、临床成功(术后无内漏)、院内死亡和主要不良事件。结果:pra 3例,TAAAs 4例,主动脉弓动脉瘤3例,其中肾-肠系膜动脉12例,左锁骨下动脉3例经内支合并。技术成功率为90.0%(9/10)/例,93.3%(14/15)/条血管。临床成功率90%(9/10)。有2人在医院死亡,与动脉瘤无关。2例患者分别发生截瘫和淋雨栓塞。3例患者术后通气时间延长3天。4例患者出现动脉瘤囊收缩,1例患者在随访6个多月后动脉瘤大小稳定。没有患者需要干预。结论:PMiBEVAR是治疗复杂动脉瘤高危患者的一种可行方法。该技术在提高解剖适应性、无时间延迟、实用性等方面对许多国家现有技术有一定的补充作用。然而,其长期耐久性仍不确定。需要进一步的大规模和长期研究。临床影响:这是第一个研究医生改良的内分支血管内修复(PMiBEVAR)结果的临床研究。PMiBEVAR治疗肾旁动脉瘤、胸腹主动脉瘤或主动脉弓动脉瘤是一种可行的手术方法。该技术可能在改进解剖适应性(与现成设备相比)、无时间延迟(与定制设备相比)以及在许多国家实施的潜力方面补充现有技术。另一方面,手术时间因情况而异,这表明需要学习曲线和技术创新来进行更一致的手术。
{"title":"Initial Outcomes of Physician-Modified Inner Branched Endovascular Repair in High-Surgical-Risk Patients.","authors":"Tsuyoshi Shibata, Yutaka Iba, Tomohiro Nakajima, Junji Nakazawa, Akihito Ohkawa, Itaru Hosaka, Ayaka Arihara, Shingo Tsushima, Keishi Ogura, Kenta Yoshikawa, Nobuyoshi Kawaharada","doi":"10.1177/15266028231169183","DOIUrl":"10.1177/15266028231169183","url":null,"abstract":"<p><strong>Purpose: </strong>To report the initial outcomes of physician-modified inner branched endovascular repair (PMiBEVAR) for pararenal aneurysms (PRAs), thoracoabdominal aortic aneurysms (TAAAs), and aortic arch aneurysms in high-surgical-risk patients.</p><p><strong>Materials and methods: </strong>A total of 10 patients (6 men; median age, 83.0 years) treated using PMiBEVAR were enrolled in this retrospective, single-center study. All patients were at high surgical risk because of severe comorbidities (American Society of Anesthesiologists physical status score≥3 or emergency repair). End points were defined as technical success per patient and per vessel (successful deployment), clinical success (no endoleaks postoperatively), in-hospital death, and major adverse events.</p><p><strong>Results: </strong>There were 3 PRAs, 4 TAAAs, and 3 aortic arch aneurysms with 12 renal-mesenteric arteries and 3 left subclavian arteries incorporated by inner branches. The technical success rate was 90.0% (9/10) per patient and 93.3% (14/15) per vessel. The clinical success rate was 90% (9/10). There were 2 in-hospital deaths, unrelated to aneurysms. Paraplegia and shower emboli occurred separately in 2 patients. Three patients experienced prolonged ventilation for 3 days after surgery. Aneurysm sac shrinkage occurred in 4 patients, and aneurysm size stabilized in 1 patient during follow-up, more than 6 months later. None of the patients required intervention.</p><p><strong>Conclusion: </strong>PMiBEVAR is a feasible approach for treating complex aneurysms in high-surgical-risk patients. This technology may complement the existing technology in terms of improved anatomical adaptability, no time delay and practicability in many countries. However, long-term durability remains undetermined. Further large-scale and long-term studies are needed.</p><p><strong>Clinical impact: </strong>This is the first clinical study to investigate outcomes of physician-modified inner branched endovascular repair (PMiBEVAR). PMiBEVAR for treating pararenal aneurysm, thoracoabdominal aortic aneurysm, or aortic arch aneurysm is a feasible procedure. This technology is likely to complement existing technology in terms of improved anatomical adaptability (compared to off-the-shelf devices), no time delay (compared to custom-made devices), and the potential to be performed in many countries. On the other hand, surgery time varied greatly depending on the case, suggesting a learning curve and the need for technological innovation to perform more consistent surgeries.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"185-191"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9409529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Endovascular Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1